- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Coaching Changes
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Novavax sales tumble 75%, will cut another $300M in expenses
Posted on 11/9/23 at 1:42 pm
Posted on 11/9/23 at 1:42 pm
LINK
'one of our key objectives is to strengthen the financial stability of the company....'
Novavax has already reduced year-to-date operating expenses by $950 million, or 47% compared to 2022
The company’s updated COVID-19 booster shot, which received U.S. regulatory approval this fall, is now available in more than 14,000 pharmacies, including Costco, CVS, Giant, Publix, Rite Aid and Stop & Shop. Novavax expects U.S. demand for the vaccine for the 2023-2024 season to be between 30 million and 50 million doses.
Novavax expects to begin Phase 3 clinical trials for its combination vaccine in the second half of 2024, with possible approval as early as 2026.
I'm sure the push for this combo which only clowns will ask for has little to do with revenue and a lot to do with concern for public health.
'one of our key objectives is to strengthen the financial stability of the company....'
Novavax has already reduced year-to-date operating expenses by $950 million, or 47% compared to 2022
The company’s updated COVID-19 booster shot, which received U.S. regulatory approval this fall, is now available in more than 14,000 pharmacies, including Costco, CVS, Giant, Publix, Rite Aid and Stop & Shop. Novavax expects U.S. demand for the vaccine for the 2023-2024 season to be between 30 million and 50 million doses.
Novavax expects to begin Phase 3 clinical trials for its combination vaccine in the second half of 2024, with possible approval as early as 2026.
I'm sure the push for this combo which only clowns will ask for has little to do with revenue and a lot to do with concern for public health.
3
Posted on 11/9/23 at 1:43 pm to conservativewifeymom
Wasn't this the one made with traditional methods and not the mRNA tech?
Posted on 11/9/23 at 1:48 pm to TrueTiger
You are correct, it is protein-based not mRna-based.
Still, I find the combo problematic. It's also possible that the mRNA proponents are trying to push them out of the competitive arena.
Still, I find the combo problematic. It's also possible that the mRNA proponents are trying to push them out of the competitive arena.
Posted on 11/9/23 at 1:50 pm to conservativewifeymom
Funny how covid is no more yet trials are still ongoing for these experimental vaccines
Posted on 11/9/23 at 1:52 pm to TrueTiger
quote:
Wasn't this the one made with traditional methods and not the mRNA tech?
Yes
Posted on 11/9/23 at 1:52 pm to conservativewifeymom
This is the one I was interested in two years ago. However, now that we know the threat of Covid, and the lack of need for shots for Covid, Novavax has missed the train on timing. It would have made a crap ton of money had it had its shite together two years ago.
Posted on 11/9/23 at 1:56 pm to Northshoretiger87
Imagine creating a drug for which you have ZERO liability, an entire Fed Gov mandating its use……and you STILL can’t make money!
Page 1 of 1
Popular
Back to top
Follow TigerDroppings for LSU Football News